Search PDMR transactions

Notifier
Name of person with notification obligation
Donato Spota
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Donato Spota
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Hansa Biopharma AB
Issuer´s LEI code
549300LLEO25ZJJ3NT91
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Hansa Biopharma AB SE0002148817 Acquisition 10,311 Quantity 0.00 SEK 17/06/2022 Outside a trading venue
Share Hansa Biopharma AB SE0002148817 Disposal 4,638 Quantity 49.99 SEK 17/06/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Hansa Biopharma AB SE0002148817 Acquisition 17/06/2022 Outside a trading venue 10,311 (Quantity) 0.00 SEK
Hansa Biopharma AB SE0002148817 Disposal 17/06/2022 NASDAQ STOCKHOLM AB 4,638 (Quantity) 49.99 SEK
<< Back